News

MIT Technology Review4h
Here’s what food and drug regulation might look like under the Trump administration
Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...
American Council on Science and Health1dOpinion
The Audacity of Hype: Reimagining the FDA, One Shortcut at a Time
When two of medicine’s most outspoken reformers publish a roadmap for the FDA, you expect at least coherence. Instead, we get ...
Le Lézard1d
Medtronic announces MiniMed as name for planned New Diabetes Company
Medtronic plc , a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following the intended separation. The name honors the company's ...
BioSpace1d
Makary, Prasad Lay Out Mission for FDA in Journal Kennedy Called ‘Corrupt’
FDA Commissioner Marty Makary and CBER Director Vinay Prasad published an article in JAMA on Tuesday outlining the FDA’s ...
kffhealthnews2d
FDA Leans Into AI Models As Replacement For Animal Testing
FDA Commissioner Martin Makary said this move would offer newer treatments for patients quicker, while also reducing the cost of research and development. Other news includes: lab models of pain ...
F.D.A. to Use A.I. in Drug Approvals to ‘Radically Increase Efficiency’
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...
MedPage Today2d
FDA Officials Lay Out Vision for Agency
The new FDA commissioner and Center for Biologics Evaluation and Research (CBER) director laid out their vision for the ...
Opinion
Science-Based Medicine3dOpinion
Marty Makary and Vinay Prasad embrace a “more fluid concept of evidence” at the FDA
Last Thursday during a roundtable on stem cell therapies, new FDA Commissioner Marty Makary referred to EBM levels of evidence as an artificial and dogmatic construct. Apparently Dr. David Katz's "mor ...